Panel Discussion: Uniting Industry & Academia to Accelerate Cell Therapy Development for Autoimmune Disease
Moderator – Greg Deener, Chief Executive Officer, iCell Gene Therapeutics
Time: 11:30 am
day: Day One Track B, AM
Details:
• How can we foster increased partnerships between industry and academic/clinical institutions to strengthen our understanding of current autoimmune indications?
• How do we build on the established experiences where academic clinical trials provided early POC for cell therapy in AID to attract investment and clinical development and commercialization of cell therapies in the autoimmune space?
